ASCP 2019 Novel Med May Curb Obsessions in Binge Eating Disorder The novel dopamine/norepinephrine reuptake inhibitor dasotraline reduces number of binge-eating days, as well as obsessions and ...
DUBLIN, May 22, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from its mental health portfolio at the American Society of Clinical Psychopharmacology (ASCP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback